Predictive variable | Coefficient | 95% CI | p | |
lower | upper | |||
Model 1 | ||||
PCAM | 0.054 | 0.038 | 0.070 | 0.001 |
Age | 0.0098 | −0.000082 | 0.020 | 0.052 |
Gender | −0.19 | −0.43 | 0.045 | 0.11 |
Model 2 | ||||
PCAM | 0.055 | 0.036 | 0.074 | 0.001 |
Age | 0.0094 | −0.0014 | 0.020 | 0.088 |
Gender | −0.20 | −0.45 | 0.048 | 0.1 |
Mini Nutritional Assessment Short-Form | −0.000059 | −0.039 | 0.039 | 1.00 |
Charlson Comorbidity Index | 0.000096 | −0.061 | 0.062 | 1.00 |
Serum sodium concentration | 0.0096 | −0.012 | 0.032 | 0.39 |
No. of medications | −0.011 | −0.044 | 0.021 | 0.50 |
Requiring public assistance | 0.089 | −0.21 | 0.39 | 0.57 |
Model 3 | ||||
Medicine-oriented complexity | 0.076 | 0.031 | 0.12 | 0.001 |
Patient-oriented complexity | 0.041 | 0.012 | 0.071 | 0.006 |
Age | 0.0090 | −0.00094 | 0.019 | 0.076 |
Gender | −0.21 | −0.45 | 0.029 | 0.085 |
Model 4 | ||||
Medicine-oriented complexity | 0.083 | 0.035 | 0.13 | 0.001 |
Patient-oriented complexity | 0.039 | 0.0080 | 0.071 | 0.014 |
Age | 0.0083 | −0.0026 | 0.019 | 0.14 |
Gender | −0.23 | −0.48 | 0.023 | 0.075 |
Mini Nutritional Assessment Short-Form | −0.0016 | −0.041 | 0.038 | 0.94 |
Charlson Comorbidity Index | −0.0075 | −0.070 | 0.055 | 0.81 |
Serum sodium concentration | 0.010 | −0.012 | 0.032 | 0.36 |
No. of medications | −0.0092 | −0.042 | 0.023 | 0.58 |
Requiring public assistance | 0.12 | −0.19 | 0.43 | 0.44 |
PCAM, Patient Centred Assessment Method.